HELSINKI, March 21 (Xinhua) -- Europe's medical regulator said on Thursday that European Union (EU) countries should continue to use the AstraZeneca vaccine because its benefits outweigh risks.
The news somehow relieved worries that controversies over AstraZeneca would further delay the vaccination process in the EU, which is already slow due to insufficient supplies.
But more needs to be done when Europe right now is facing a new wave of infections.
Produced by Xinhua Global Service■
